
PANGAEA Oncology
PANG | BME Growth
Overview
Corporate Details
- ISIN(s):
- ES0105221008
- LEI:
- 959800TSRNQZYHX37Y29
- Country:
- Spain
- Address:
- C/ COSO 42 4º, 50004 Zaragoza
- Website:
- https://panoncology.com/
- Sector:
- Human health and social work activities
- Industry:
- Other human health activities
Description
PANGAEA Oncology is a medical services company specializing in precision oncology, dedicated to improving the survival and quality of life for cancer patients. Founded in 2007, the company provides services to both patients and the pharmaceutical industry. Its offerings include advanced molecular diagnostics, validation for companion diagnostic (Dx) platforms, and a range of preclinical R&D services such as biomarker discovery, in-vitro testing, and organoid technology. A key innovator, PANGAEA was the first laboratory in Spain to be accredited for liquid biopsy techniques. By operating directly within hospital settings, the company accelerates clinical trials by providing direct access to patients, samples, and clinical data, positioning itself as a leading recruitment center. PANGAEA leverages genetic analyses and data-driven approaches to advance personalized cancer treatment and research.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for PANGAEA Oncology.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
No filings match the current criteria. |
Automate Your Workflow. Get a real-time feed of all PANGAEA Oncology filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for PANGAEA Oncology via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |